KV Network

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield
Decrease Font Size Increase Font Size Text Size Print This Page

New Delhi, Apr 12 (PTI) Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.

He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.

Reacting to reports of COVID-19 vaccines shortage, he said manufacturers are ready but there has been no demand.


KV Network

Kashmir Vision cover all daily updates for the newspaper

Leave a Reply

Your email address will not be published. Required fields are marked *